• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Stimulant Treatment Effect on Anxiety in ADHD
Research Update

Stimulant Treatment Effect on Anxiety in ADHD

April 1, 2023
Gaurav Mishra, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Gaurav Mishra, MD. Dr. Mishra has no financial relationships with companies related to this material.

REVIEW OF: Soul O et al, J Child Adolesc Psychopharmacol 2021;31(9):639–644

STUDY TYPE: Prospective, open label

Anxiety is one of the many side effects commonly listed for stimulant medications. Although a 2015 meta-analysis showed that stimulants did not worsen anxiety symptoms in children with ADHD compared to placebo, none of the studies included in that paper used prospective methodology (Coughlin CG et al, J Child Adolesc Psychopharmacol 2015;25(8):611–617). Now Soul and colleagues have published the first prospective study looking at whether stimulants exacerbate anxiety.

This 12-week study recruited 104 children ages 6–15 years at the beginning of their stimulant treatment for ADHD. Parents filled out the ADHD-RS and SCARED anxiety scales. Of the 57 participants who finished the study, 18 had a diagnosis of an anxiety disorder: Eight had separation anxiety disorder, two had generalized anxiety disorder, four had social anxiety disorder, one had panic disorder, and three had a specific anxiety disorder. The prescribed stimulants included long-acting methylphenidate for 51.8% of participants, with other prescriptions split among osmotic-release oral system methylphenidate, lisdexamfetamine, mixed amphetamine salts, dexmethylphenidate, and immediate-release methylphenidate.

ADHD symptoms improved as expected with stimulants, and the SCARED scale showed that 19% of patients reported reductions in anxiety. There were significant decreases on subdomains of generalized anxiety disorder, separation anxiety disorder, and a school-avoidant behavior subscale, but the effect sizes were small—none beyond 0.14. The presence or absence of anxiety disorders did not impact the improvement of ADHD symptoms based on ADHD-RS. About 14% of the patients reported side effects of irritability, tension, and anxiety symptoms, and 12% reported depressive symptoms.

This study was limited by its open-label design, lack of a control group, small sample size, and loss of patients. Still, its prospective naturalistic design and the use of validated scales along with inclusion of children with anxiety disorder strengthens the results.

Carlat Take

While it will be helpful to have better-controlled studies, for now we have some reassurance that you are unlikely to cause or worsen anxiety when you use stimulants to treat anxious kids with ADHD.

Child Psychiatry Research Update
KEYWORDS ADHD anxiety attention deficit hyperactivity disorder depression irritability stimulant-treatment
    Gaurav Mishra, MD

    More from this author
    www.thecarlatreport.com
    Issue Date: April 1, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Autism in Children and Adolescents, CCPR, April/May/June 2023
    Treating Irritability in Autism: Functional and Medication Approaches
    Addressing Suicidality in Autistic Children and Teens
    Recognizing and Treating Psychosis in Autism
    Autistic Drivers Perform Well
    Testing Neurofeedback for ADHD
    Is It Worth Adding Coenzyme Q10 to Atomoxetine for ADHD?
    Does Treatment of ADHD Help Caregiver Stress?
    Stimulant Treatment Effect on Anxiety in ADHD
    Why Do So Many Pediatric Antidepressant Research Trials “Fail”?
    CME Post-Test, Autism in Children and Adolescents, CCPR, April/May/June 2023
    DOWNLOAD NOW
    Featured Book
    • PB4e_Cover2.png

      Psychiatry Practice Boosters, Fourth Edition (2023)

      Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.